Literature DB >> 33668580

Implications of Breast Cancer Chemotherapy-Induced Inflammation on the Gut, Liver, and Central Nervous System.

Taurean Brown1,2,3, DeLawrence Sykes4, Antiño R Allen1,2,3.   

Abstract

Breast Cancer is still one of the most common cancers today; however, with advancements in diagnostic and treatment methods, the mortality and survivorship of patients continues to decrease and increase, respectively. Commonly used treatments today consist of drug combinations, such as doxorubicin and cyclophosphamide; docetaxel, doxorubicin, and cyclophosphamide; or doxorubicin, cyclophosphamide, and paclitaxel. Although these combinations are effective at destroying cancer cells, there is still much to be understood about the effects that chemotherapy can have on normal organ systems such as the nervous system, gastrointestinal tract, and the liver. Patients can experience symptoms of cognitive impairments or "chemobrain", such as difficulty in concentrating, memory recollection, and processing speed. They may also experience gastrointestinal (GI) distress symptoms such as diarrhea and vomiting, as well as hepatotoxicity and long term liver damage. Chemotherapy treatment has also been shown to induce peripheral neuropathy resulting in numbing, pain, and tingling sensations in the extremities of patients. Interestingly, researchers have discovered that this array of symptoms that cancer patients experience are interconnected and mediated by the inflammatory response.

Entities:  

Keywords:  cyclophosphamide; docetaxel; doxorubicin; paclitaxel

Year:  2021        PMID: 33668580      PMCID: PMC7917715          DOI: 10.3390/biomedicines9020189

Source DB:  PubMed          Journal:  Biomedicines        ISSN: 2227-9059


  144 in total

1.  Tibetan sound meditation for cognitive dysfunction: results of a randomized controlled pilot trial.

Authors:  K Milbury; A Chaoul; K Biegler; T Wangyal; A Spelman; C A Meyers; B Arun; J L Palmer; J Taylor; L Cohen
Journal:  Psychooncology       Date:  2013-05-09       Impact factor: 3.894

Review 2.  Effects of systemic chemotherapy on the liver.

Authors:  Giuliano Ramadori; Silke Cameron
Journal:  Ann Hepatol       Date:  2010 Apr-Jun       Impact factor: 2.400

3.  Paclitaxel-induced neuropathic pain is age dependent and devolves on glial response.

Authors:  J Ruiz-Medina; A Baulies; S A Bura; O Valverde
Journal:  Eur J Pain       Date:  2012-05-24       Impact factor: 3.931

4.  5-Fluorouracil can cross brain-blood barrier and cause encephalopathy: should we expect the same from capecitabine? A case report on capecitabine-induced central neurotoxicity progressing to coma.

Authors:  V Formica; A Leary; D Cunningham; Y J Chua
Journal:  Cancer Chemother Pharmacol       Date:  2005-12-07       Impact factor: 3.333

5.  Cognitive impairment in primary biliary cirrhosis: symptom impact and potential etiology.

Authors:  Julia L Newton; Kieren G Hollingsworth; Roy Taylor; Ahmed M El-Sharkawy; Zia Uda Khan; Ruth Pearce; Kathryn Sutcliffe; Oke Okonkwo; Adrian Davidson; Jennifer Burt; Andrew M Blamire; David Jones
Journal:  Hepatology       Date:  2008-08       Impact factor: 17.425

6.  Effect of alcoholic extract of aerial parts of Rosmarinus officinalis L. on pain, inflammation and apoptosis induced by chronic constriction injury (CCI) model of neuropathic pain in rats.

Authors:  Mahboobeh Rahbardar Ghasemzadeh; Bahareh Amin; Soghra Mehri; Seyed Javad Mirnajafi-Zadeh; Hossein Hosseinzadeh
Journal:  J Ethnopharmacol       Date:  2016-08-23       Impact factor: 4.360

Review 7.  Autoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: more than a gut feeling.

Authors:  Emily G Severance; Robert H Yolken; William W Eaton
Journal:  Schizophr Res       Date:  2014-07-15       Impact factor: 4.939

8.  Chemotherapy induced liver abnormalities: an imaging perspective.

Authors:  Ankush Sharma; Roozbeh Houshyar; Priya Bhosale; Joon-Il Choi; Rajesh Gulati; Chandana Lall
Journal:  Clin Mol Hepatol       Date:  2014-09

9.  Gut microbiome alterations in Alzheimer's disease.

Authors:  Nicholas M Vogt; Robert L Kerby; Kimberly A Dill-McFarland; Sandra J Harding; Andrew P Merluzzi; Sterling C Johnson; Cynthia M Carlsson; Sanjay Asthana; Henrik Zetterberg; Kaj Blennow; Barbara B Bendlin; Federico E Rey
Journal:  Sci Rep       Date:  2017-10-19       Impact factor: 4.379

10.  Proteomic and functional annotation analysis of injured peripheral nerves reveals ApoE as a protein upregulated by injury that is modulated by metformin treatment.

Authors:  Ohannes K Melemedjian; Hussein N Yassine; Adia Shy; Theodore J Price
Journal:  Mol Pain       Date:  2013-03-26       Impact factor: 3.395

View more
  6 in total

Review 1.  Chemobrain in Breast Cancer: Mechanisms, Clinical Manifestations, and Potential Interventions.

Authors:  Giovana R Onzi; Nathalia D'Agustini; Solange C Garcia; Silvia S Guterres; Paula R Pohlmann; Daniela D Rosa; Adriana R Pohlmann
Journal:  Drug Saf       Date:  2022-05-23       Impact factor: 5.606

Review 2.  Toll-like receptor-mediated neuroinflammation: relevance for cognitive dysfunctions.

Authors:  Silvia Squillace; Daniela Salvemini
Journal:  Trends Pharmacol Sci       Date:  2022-06-23       Impact factor: 17.638

Review 3.  Cognitive adverse effects of chemotherapy and immunotherapy: are interventions within reach?

Authors:  Sanne B Schagen; Andrey S Tsvetkov; Annette Compter; Jeffrey S Wefel
Journal:  Nat Rev Neurol       Date:  2022-02-09       Impact factor: 44.711

4.  Oxidative Stress and Inflammation: From Mechanisms to Therapeutic Approaches.

Authors:  Juan Gambini; Kristine Stromsnes
Journal:  Biomedicines       Date:  2022-03-23

Review 5.  Animal models of chemotherapy-induced cognitive decline in preclinical drug development.

Authors:  Jeena John; Manas Kinra; Jayesh Mudgal; G L Viswanatha; K Nandakumar
Journal:  Psychopharmacology (Berl)       Date:  2021-10-13       Impact factor: 4.415

6.  Neurotoxic Effect of Doxorubicin Treatment on Cardiac Sympathetic Neurons.

Authors:  Nicola Moro; Lolita Dokshokova; Induja Perumal Vanaja; Valentina Prando; Sophie Julie A Cnudde; Anna Di Bona; Riccardo Bariani; Leonardo Schirone; Barbara Bauce; Annalisa Angelini; Sebastiano Sciarretta; Alessandra Ghigo; Marco Mongillo; Tania Zaglia
Journal:  Int J Mol Sci       Date:  2022-09-21       Impact factor: 6.208

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.